title: Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease.
abstract: The activity of the astrocytic enzyme glutamine synthetase (GS) is decreased in the Alzheimer's disease brain, which may have relevance to mechanisms of chronic excitotoxicity. The molecular perturbation(s) that results in GS inactivation is not known, although oxidative lesioning of the enzyme is one likely cause. To assess structural perturbation induced in GS by metal-catalyzed oxidation, a series of spin-labeling studies were undertaken. Ovine GS was oxidized by exposure to iron/hydrogen peroxide and subsequently labeled with the thiol-specific nitroxide probe MTS [(1-oxyl-2,2,5,5-tetramethyl-pyrroline-3-methyl)methanethiosulfonate]. The reaction of MTS with cysteine residues within GS was monitored in real time by electron paramagnetic resonance spectrometry. Structural perturbation of GS, manifested as decreased thiol accessibility, was inferred from an apparent decrease in the rate constant for the second-order reaction of MTS with protein thiols. A subsequent spin-labeling study was undertaken to compare the structural integrity of GS purified and isolated from Alzheimer's disease-afflicted brain (AD-GS) with that of GS isolated from nondemented, age-matched control brain (C-GS). The rate constant for reaction of MTS with AD-GS was markedly decreased relative to that for the reaction of spin label with C-GS. The kinetic data were partially corroborated by spectroscopic data obtained from circular dichroism analysis of control and peroxide-treated ovine GS. In an adjunct experiment, the interaction of GS with a synthetic analogue of the Alzheimer's-associated beta-amyloid peptide, known to induce free radical oxidative stress, indicated strong interaction of the enzyme with the peptide as reflected by a decrease in the rate constant for MTS binding to reactive protein thiols.
authors.affiliation: Department of Chemistry and Center of Membrane Sciences, University of Kentucky, Lexington 40506-0057, U.S.A.
authors.forename: D A
authors.initials: DA
authors.lastname: Butterfield
authors.forename: K
authors.initials: K
authors.lastname: Hensley
authors.forename: P
authors.initials: P
authors.lastname: Cole
authors.forename: R
authors.initials: R
authors.lastname: Subramaniam
authors.forename: M
authors.initials: M
authors.lastname: Aksenov
authors.forename: M
authors.initials: M
authors.lastname: Aksenova
authors.forename: P M
authors.initials: PM
authors.lastname: Bummer
authors.forename: B E
authors.initials: BE
authors.lastname: Haley
authors.forename: J M
authors.initials: JM
authors.lastname: Carney
mesh_terms: D000544:Alzheimer Disease / Q000378:metabolism*; D000682:Amyloid / Q000378:metabolism; D003497:Cyclic N-Oxides / Q000378:metabolism / Q000494:pharmacology; D005609:Free Radicals / Q000378:metabolism; D005974:Glutamate-Ammonia Ligase / Q000737:chemistry* / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D008698:Mesylates; D010084:Oxidation-Reduction; D018384:Oxidative Stress / Q000502:physiology; D013113:Spin Labels
chemical_list: D000682:Amyloid; D003497:Cyclic N-Oxides; D005609:Free Radicals; D008698:Mesylates; D013113:Spin Labels; C034248:(1-oxyl-2,2,5,5-tetramethylpyrroline-3-methyl)methanethiosulfonate; D005974:Glutamate-Ammonia Ligase